PAVM
PAVM
NASDAQ · Health Care

Pavmed Inc

$1.61
+0.05 (+2.88%)
Financial Highlights (FY 2026)
Revenue
884.1K
Net Income
4.99M
Gross Margin
-207.0%
Profit Margin
564.8%
Rev Growth
-42.8%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 884.1K 1.55M 6.38M 6.70M
Gross Profit -1,830,496 -3,201,847 2.81M 2.95M
Operating Income -272,261,339 -428,608,020 548.6K 488.5K
Net Income 4.99M 7.86M 418.8K 465.2K
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Rev Growth -42.8% -42.8% +12.0% -1.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.61M 1.61M 2.13M 1.84M
Total Equity 4.94M 4.94M 6.09M 6.42M
D/E Ratio 0.33 0.33 0.35 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -270,943,740 -450,230,108 672.1K 715.5K
Free Cash Flow — — 349.1K 300.8K